Left Ventricular Mass Regression following Implantation of St. Jude Medical Trifecta Aortic Bioprosthesis

Ja Chacko,J Edlin,Ks Lall,Ah Sepehripour,Sg Ambekar

doi:10.1186/1749-8090-10-s1-a308

Ja Chacko, J Edlin + Show 3 more

Open Access

https://doi.org/10.1186/1749-8090-10-s1-a308

Copy DOI

Abstract

The St. Jude Medical Trifecta aortic supra-annular bioprosthesis is regarded as the next generation in pericardial stented tissue valves. The unique design of tissue leaflets attached to the exterior of the valve stent provides unrivalled in-vivo mean gradients and haemodynamics.

Highlights

Left Ventricular Mass Regression following Implantation of St. Jude Medical Trifecta Aortic Bioprosthesis
The unique design of tissue leaflets attached to the exterior of the valve stent provides unrivalled in-vivo mean gradients and haemodynamics
Further consistent 2-D measurements are required across the cohort to establish this relationship

Summary

Introduction

Left Ventricular Mass Regression following Implantation of St. Jude Medical Trifecta Aortic Bioprosthesis JA Chacko, J Edlin, AH Sepehripour, SG Ambekar, KS Lall* From World Society of Cardiothoracic Surgeons 25th Anniversary Congress, Edinburgh Edinburgh, UK. Background/Introduction The St. Jude Medical Trifecta aortic supra-annular bioprosthesis is regarded as the generation in pericardial stented tissue valves.

Results

Conclusion